Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics

劳工日休市 08-29 16:00:00 EDT

0.2150

-0.0130

-5.70%

盘后0.4726

+0.2576+119.81%

19:59 EDT

最高0.2331	最低0.2106	成交量9,163万
今开0.2290	昨收0.2280	日振幅9.87%
总市值898.44万	流通市值672.00万	总股本4,179万
成交额2,025万	换手率293.16%	流通股本3,126万
市净率-0.20	ROE-362.79%	每股收益-1.18
52周最高1.27	52周最低0.1417	市盈率-0.18
股息0.00	股息收益率0.00	ROA-85.68%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":0.215,"timestamp":1756497600000,"preClose":0.228,"halted":0,"volume":91629915,"hourTrading":{"tag":"盘后","latestPrice":0.4726,"preClose":0.215,"latestTime":"19:59 EDT","volume":91064957,"amount":47387612.555301,"timestamp":1756511999678},"delay":0,"floatShares":31255753,"shares":41788096,"eps":-1.183375,"marketStatus":"劳工日休市","change":-0.013,"latestTime":"08-29 16:00:00 EDT","open":0.229,"high":0.2331,"low":0.2106,"amount":20253751.7949156,"amplitude":0.098684,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.183375,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.228,"preHourTrading":{"tag":"盘前","latestPrice":0.2331,"preClose":0.2285,"latestTime":"09:22 EDT","volume":310,"amount":72.1128975,"timestamp":1756473775568},"postHourTrading":{"tag":"盘后","latestPrice":0.4726,"preClose":0.215,"latestTime":"19:59 EDT","volume":91064957,"amount":47387612.555301,"timestamp":1756511999678},"volumeRatio":157.24480312238825},"requestUrl":"/m/hq/s/CARM","defaultTab":"news","newsList":[{"id":"2558579887","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558579887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558579887?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:12","pubTimestamp":1754673123,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时12分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌5.02%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011203a6db6c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011203a6db6c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2557543813","title":"这家公司裁员95%公司仅剩6人","url":"https://stock-news.laohu8.com/highlight/detail?id=2557543813","media":"制药界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557543813?lang=zh_cn&edition=full","pubTime":"2025-08-08 14:27","pubTimestamp":1754634434,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics近期宣布了一项重大裁员计划，将公司员工从46人削减至仅6人，占总员工数的约87%。财务状况与运营资金 截至2024年底，Carisma Therapeutics的现金及现金等价物为1790万美元，预计可维持公司运营至2025年下半年。为了减少运营开支，公司决定进行大规模裁员，预计裁员将产生约380万美元的费用，主要用于员工离职福利。公司计划在2025年第一季度为其肝纤维化项目提名一个开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143055a47c924f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143055a47c924f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2557756792","title":"Carisma Therapeutics, Inc.盘中异动 急速下跌6.29%报0.286美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557756792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557756792?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:46","pubTimestamp":1754581587,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时46分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水6.29%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234627a6d929a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234627a6d929a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CARM","BK4539"],"gpt_icon":0},{"id":"2550757744","title":"Carisma Therapeutics, Inc.7月8日成交额为26.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550757744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550757744?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:26","pubTimestamp":1752024416,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Carisma Therapeutics, Inc.成交额为26.06万美元，成交额较昨日增加29.71%，当日成交量为65.72万股。Carisma Therapeutics, Inc.于2025年7月8日涨1.77%，报0.402美元，该股过去5个交易日涨2.55%，年初至今跌4.06%，过去60日涨103.03%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092700a43f0c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092700a43f0c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CARM","BK4007","LENZ"],"gpt_icon":0},{"id":"2549530567","title":"Carisma Therapeutics, Inc.7月7日成交额为20.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530567?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:26","pubTimestamp":1751937972,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Carisma Therapeutics, Inc.成交额为20.09万美元，成交额较昨日增加23.03%，当日成交量为49.53万股。Carisma Therapeutics, Inc.于2025年7月7日跌1.99%，报0.395美元，该股过去5个交易日跌1.5%，年初至今跌5.73%，过去60日涨124.43%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092623a43ccffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092623a43ccffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CARM","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2548832748","title":"Carisma Therapeutics, Inc.7月1日成交额为45.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832748?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:27","pubTimestamp":1751419625,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Carisma Therapeutics, Inc.成交额为45.01万美元，成交额较昨日减少3.79%，当日成交量为115.27万股。Carisma Therapeutics, Inc.于2025年7月1日涨3.4%，报0.405美元，该股过去5个交易日跌5.4%，年初至今跌3.37%，过去60日涨110.89%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CARM","BK4007","LENZ"],"gpt_icon":0},{"id":"2548042270","title":"Carisma Therapeutics, Inc.6月30日成交额为46.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548042270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548042270?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:25","pubTimestamp":1751333141,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Carisma Therapeutics, Inc.成交额为46.79万美元，成交额较昨日增加29.51%，当日成交量为118.94万股。Carisma Therapeutics, Inc.于2025年6月30日跌2.25%，报0.392美元，该股过去5个交易日跌13.17%，年初至今跌6.54%，过去60日涨76.4%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CARM","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2545484417","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545484417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545484417?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:43","pubTimestamp":1750686186,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时43分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下跌6.85%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214306978b575d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214306978b575d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","CARM","LENZ"],"gpt_icon":0},{"id":"2544178508","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.51%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544178508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544178508?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:35","pubTimestamp":1750426512,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时35分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨5.51%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213512a4b4c047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213512a4b4c047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CARM","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2544903936","title":"Carisma Therapeutics, Inc.盘中异动 大幅下挫6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544903936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544903936?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:30","pubTimestamp":1750253457,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时30分，Carisma Therapeutics, Inc.股票出现异动，股价大幅跳水6.64%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213057a7109593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213057a7109593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CARM","LENZ","BK4007"],"gpt_icon":0},{"id":"2544198099","title":"Carisma Therapeutics, Inc.6月16日成交额为182.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544198099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544198099?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:28","pubTimestamp":1750123695,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Carisma Therapeutics, Inc.成交额为182.82万美元，成交额较昨日减少74.75%，当日成交量为409.43万股。Carisma Therapeutics, Inc.于2025年6月16日跌4.85%，报0.43美元，该股过去5个交易日涨89.3%，年初至今涨2.55%，过去60日涨3.29%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092819a70d306c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092819a70d306c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","CARM"],"gpt_icon":1},{"id":"2543651485","title":"Carisma Therapeutics, Inc.6月13日成交额为723.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651485?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:28","pubTimestamp":1749864483,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Carisma Therapeutics, Inc.成交额为723.90万美元，成交额较昨日增加13.23%，当日成交量为1276.51万股。Carisma Therapeutics, Inc.于2025年6月13日跌17.62%，报0.452美元，该股过去5个交易日涨132.78%，年初至今涨7.78%，过去60日涨7.52%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092811a7088ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092811a7088ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CARM","BK4539"],"gpt_icon":1},{"id":"2542540625","title":"Carisma Therapeutics, Inc.6月11日成交额为2355.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542540625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542540625?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:27","pubTimestamp":1749691671,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Carisma Therapeutics, Inc.成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4539","BK4139","BK4007"],"gpt_icon":1},{"id":"2542023317","title":"Carisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542023317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542023317?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:31","pubTimestamp":1749562279,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨225.35%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CARM","LENZ","BK4539"],"gpt_icon":0},{"id":"2541867540","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨6.18%报0.198美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541867540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541867540?lang=zh_cn&edition=full","pubTime":"2025-06-07 02:08","pubTimestamp":1749233286,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日02时08分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升6.18%。截至发稿，该股报0.198美元/股，成交量12.9421万股，换手率0.31%，振幅4.73%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607020806a49d33b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607020806a49d33b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2540079195","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540079195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540079195?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:59","pubTimestamp":1748876351,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时59分，Carisma Therapeutics, Inc.股票出现波动，股价大幅上涨6.14%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225912976e8fe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225912976e8fe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CARM","BK4007","LENZ"],"gpt_icon":0},{"id":"2537953865","title":"Carisma Therapeutics, Inc.盘中异动 急速下跌5.24%报0.174美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537953865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537953865?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:31","pubTimestamp":1747848713,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速跳水5.24%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522013154a48719fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522013154a48719fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CARM","BK4539"],"gpt_icon":0},{"id":"2536635256","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536635256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536635256?lang=zh_cn&edition=full","pubTime":"2025-05-19 23:20","pubTimestamp":1747668020,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日23时20分，Carisma Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519232020975e77b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519232020975e77b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","CARM","LENZ","BK4139"],"gpt_icon":0},{"id":"2535315445","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速下挫5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535315445?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:31","pubTimestamp":1747402294,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价大幅下跌5.89%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213135a6e1b923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213135a6e1b923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","CARM"],"gpt_icon":0},{"id":"2534774882","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534774882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534774882?lang=zh_cn&edition=full","pubTime":"2025-05-12 22:27","pubTimestamp":1747060055,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日22时27分，Carisma Therapeutics, Inc.股票出现波动，股价大幅拉升5.51%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.90%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051222273697575030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051222273697575030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":-0.089},{"period":"1month","weight":-0.3601},{"period":"3month","weight":0.128},{"period":"6month","weight":-0.4638},{"period":"1year","weight":-0.8028},{"period":"ytd","weight":-0.4866}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CARISMA Therapeutics Inc.于2008年2月25日在特拉华州法律下成立。该公司是一家临床阶段细胞治疗公司，专注于利用专有的CAR-M细胞治疗平台开发用于治疗癌症和严重疾病的转化免疫疗法。该公司创建了一个全面的细胞治疗平台，使工程化巨噬细胞和单核细胞的治疗用途成为可能，属于白细胞的一个亚群，称为髓细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.098435},{"month":2,"riseRate":0.272727,"avgChangeRate":0.024429},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.101631},{"month":4,"riseRate":0.5,"avgChangeRate":0.251699},{"month":5,"riseRate":0.5,"avgChangeRate":0.097664},{"month":6,"riseRate":0.75,"avgChangeRate":0.216016},{"month":7,"riseRate":0.166667,"avgChangeRate":0.01871},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.045585},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.081936},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.064229},{"month":11,"riseRate":0.454545,"avgChangeRate":0.010922},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.050206}],"exchange":"NASDAQ","name":"Carisma Therapeutics","nameEN":"Carisma Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics,CARM,Carisma Therapeutics股票,Carisma Therapeutics股票老虎,Carisma Therapeutics股票老虎国际,Carisma Therapeutics行情,Carisma Therapeutics股票行情,Carisma Therapeutics股价,Carisma Therapeutics股市,Carisma Therapeutics股票价格,Carisma Therapeutics股票交易,Carisma Therapeutics股票购买,Carisma Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}